Under ESOP
Jubilant Life Sciences announced that 21,182 options under Jubilant Employees Stock Option Plan 2005 ("Plan 2005") and 92,673 options under JLL Employees Stock Option Plan 2011 ("Plan 2011") have been exercised by the option holders.Pursuant to the terms of Plan 2005 and Plan 2011, the Nomination, Remuneration and Compensation Committee of the Company (the "Committee") has approved, on 02 September 2015, transfer of 1,98,583 equity shares of Re.1 each of Jubilant Life Sciences from Jubilant Employees Welfare Trust to the eligible option holders.
Further, pursuant to the provisions of Plan 2005 read with the Scheme of Amalgamation and Demerger between the Company, Speciality Molecules, Pace Marketing Specialities and Jubilant Industries (JIL), the Committee has also approved transfer of 5,292 equity shares of Rs.10 each of JIL to the eligible option holders.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
